Clinical trials

#Clinical trials #Covid-19 #Immunology / Virology & Vaccines

Oxford coronavirus vaccine produces strong immune response in older adults

The ChAdOx1 nCov-2019 coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age. The data, published today in The Lancet, suggest that one of the groups most vulnerable to serious… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Clinical trials #Covid-19 #Vaccines

Pfizer and BioNTech conclude Phase III study of Covid-19 vaccine, showing 95% efficacy

Pfizer and BioNTech have announced that after conducting the final efficacy analysis in their ongoing Phase III study, their mRNA-based COVID-19 vaccine candidate, BNT162b2, met all of the study’s primary efficacy endpoints. Analysis of the data indicates a vaccine efficacy rate of 95% in participants without prior SARS-CoV-2 infection (first… Read More

#Covid-19 #Editor's Choice #News #Trending News

#AI / data analytics / healthtech / informatics #Clinical trials #Drug development #Therapeutics

First patient recruited for novel precision medicine trial for patients with hypertension

Closed Loop Medicine (CLM) a clinical stage therapeutics company developing drug and digital combination products, has recruited the first patient into its pivotal clinical trial investigating CLM’s integrated precision care solution for patients with hypertension. The clinical trial, called Personal COVID BP, will see up to 1,000 patients recruited for… Read More

#News

#Clinical trials #Diabetes #Drug repositioning

Diabetes drug can treat and reverse heart failure

Empagliflozin, a recently developed diabetes drug, can effectively treat and reverse heart failure in both diabetic and non-diabetic patients, according to researchers at the Icahn School of Medicine at Mount Sinai. Its clinical trial showed that this medication can improve the heart’s size, shape, and function, leading to better exercise… Read More

#News

#Clinical trials #Covid-19 #Immunology / Virology & Vaccines

Medicago and GSK start of Phase II/III clinical trials of adjuvanted COVID-19 vaccine candidate

Medicago, a biopharmaceutical company headquartered in Quebec City, and GSK are starting Phase II/III clinical trials of its plant-derived vaccine candidate for COVID-19 to evaluate its efficacy, safety, and immunogenicity. Based on the positive Phase I results, Medicago has decided to launch the Phase II/III clinical trial with GSK’s pandemic… Read More

#Covid-19 #News

#Clinical trials #Covid-19 #Immunology / Virology & Vaccines

Pfizer and BioNTech vaccine COVID-19 candidate found to be more than 90% effective

Pfizer and BioNTech have announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection, based on the first interim efficacy analysis conducted on November 8, 2020 by an external, independent Data Monitoring Committee (DMC) from the Phase… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Clinical specialities #Clinical trials #HIV

Investigational injectable cabotegravir superior to oral care for female HIV prevention

ViiV Healthcare, the global specialist HIV company has announced that an independent data safety monitoring board (DSMB) recommended the early unblinding of the HIV Prevention Trials Network (HPTN) 084 study evaluating the safety and efficacy of investigational, long-acting, injectable cabotegravir for HIV prevention in women. Following a pre-specified interim analysis,… Read More

#News

#Clinical trials #Covid-19 #Immunology / Virology & Vaccines

Analysis shows difference of up to three months in current COVID-19 vaccine trial recruitment

Analysis from virtual clinical development specialist Phesi shows the enrolment and effectiveness of two current COVID-19 vaccine trials conducted by global pharmaceutical development companies. On the surface, both trials appear to be on track to complete enrolment, however, looking deeper, there is a significant difference in the Site Effectiveness Index… Read More

#Covid-19 #News

#AI / data analytics / healthtech / informatics #Clinical trials

New digital platform assists with clinical trial organisation

Wirano is a new digital platform to help with rapid and effective organisation of clinical trials. The platform aims to revolutionise the activities involved in clinical trials by accelerating start-up of trials, optimising patient recruitment, and improving site and investigator selection processes. “The enormous cost of clinical trials in terms… Read More

#News

#Clinical trials #Covid-19 #Immunology / Virology & Vaccines

Global clinical trials of COVID-19 vaccine resume

The Food and Drug Administration (FDA) has today authorised a restart of clinical trials of the ChAdOx1 nCov-2019 Oxford coronavirus vaccine in the USA following the trials restarting in the UK, Brazil, South Africa and Japan. On 6 September, a standard review process triggered a voluntary pause to vaccination across… Read More

#Covid-19 #Editor's Choice #News

#Clinical specialities #Clinical trials #Drug repositioning #Parkinson's

Cancer anti-sickness drug offers hope for Parkinson’s hallucinations

A double-blind clinical trial, will investigate if a drug used to treat nausea in chemotherapy patients, could alleviate hallucinations in people with Parkinson’s. Parkinson’s UK, the largest charitable funder of Parkinson’s research in Europe, is partnering with UCL, and investing £1 million in a pioneering Phase II clinical trial to… Read More

#Editor's Choice #News

#Antibodies #Clinical trials #Covid-19

NIH study aims to identify promising COVID-19 treatments for larger clinical trials

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a study designed to determine whether certain approved therapies or investigational drugs in late-stage clinical development show promise against COVID-19 and merit advancement into larger clinical trials. The ACTIV-5 Big Effect Trial,… Read More

#Covid-19 #News

#Academic #AI / data analytics / healthtech / informatics #Analysis #Cellular & Molecular biology #Chemistry #Clinical trials #Drug development #Drug discovery #Narrated podcasts

The COVID-19 Race: how mouse models will help researchers cross the finish line

The emergence of SARS-CoV-2 virus and the disease it causes, COVID-19, have fuelled significant shifts in preclinical research across the globe. Amid the worldwide health emergency created by high infection rates, rapid transmission spread and relatively high mortality rates, researchers are under pressure to understand the disease’s pathogenesis, develop… Read More

#Podcasts

#AI / data analytics / healthtech / informatics #Clinical trials #Covid-19

Sector professionals believe COVID-19 must trigger a change in clinical trials

As a consequence of the coronavirus pandemic, 41% of global clinical trials in fields other than COVID-19 (c.4,5001) have been delayed or put on permanent hold. Looking ahead, 74% of life science organisations say that COVID-19 will continue to compromise their ability to deliver on clinical trial objectives for the… Read More

#News

#AI / data analytics / healthtech / informatics #Biopharma #Clinical trials #Covid-19 #Drug discovery #Therapeutics

Sitting down with…Biorelate

Daniel Jamieson is the CEO and Founder of Biorelate, a biomedical curation company that aims to accelerate insight and innovation in drug discovery. Lu Rahman spoke to him about his vision for the business, how COVID-19 has affected the landscape and the technology behind his drug discovery success. Biorelate was… Read More

#Opinion